| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4157478 | Journal of Pediatric Surgery | 2010 | 6 Pages |
Abstract
Our findings support the hypothesis that VEGF inhibition with bevacizumab transiently normalizes the dysfunctional vasculature of RMS xenografts, improving tumor oxygenation and increasing tumor sensitivity to adjuvant IR.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Adrianne L. Myers, Regan F. Williams, Cathy Y. Ng, Joseph E. Hartwich, Andrew M. Davidoff,